A randomised study of continuous infusional 5-Fluorouracil (5FU) with or without bolus mitomycin-C in patients with carcinoma of unknown primary origin

Update Il y a 4 ans
Reference: ISRCTN63374575

Extract

Not provided at time of registration


Inclusion criteria

  • Carcinoma of unknown primary origin

Links